HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ramzi M Mohammad Selected Research

apogossypolone

4/2010Preclinical studies of apogossypolone, a novel pan inhibitor of bcl-2 and mcl-1, synergistically potentiates cytotoxic effect of gemcitabine in pancreatic cancer cells.
9/2008Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivo.
2/2008Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ramzi M Mohammad Research Topics

Disease

71Neoplasms (Cancer)
05/2022 - 08/2002
24Pancreatic Neoplasms (Pancreatic Cancer)
08/2021 - 11/2005
11Lymphoma (Lymphomas)
12/2021 - 01/2005
7Adenocarcinoma
03/2020 - 05/2003
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 12/2003
5Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 04/2007
4Neoplasm Metastasis (Metastasis)
06/2021 - 06/2010
4Leukemia
01/2019 - 08/2004
4B-Cell Lymphoma (Lymphoma, B Cell)
09/2013 - 01/2005
4Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
09/2012 - 02/2008
4Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2003 - 08/2002
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
08/2004 - 08/2002
2Primitive Neuroectodermal Tumors (PNET)
10/2021 - 11/2019
2Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2021 - 11/2019
2Carcinogenesis
08/2021 - 10/2012
2Multiple Myeloma
01/2021 - 03/2016
2Inflammation (Inflammations)
01/2019 - 09/2015
2Necrosis
01/2017 - 12/2015
2Breast Neoplasms (Breast Cancer)
06/2010 - 08/2003
2Carcinoma (Carcinomatosis)
04/2009 - 03/2006
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2021
1Thyroid Neoplasms (Thyroid Cancer)
12/2019
1Anaplastic Thyroid Carcinoma
12/2019

Drug/Important Bio-Agent (IBA)

24Proteins (Proteins, Gene)FDA Link
05/2022 - 12/2002
10Pharmaceutical PreparationsIBA
05/2018 - 04/2007
7selinexorIBA
05/2022 - 02/2013
7MicroRNAs (MicroRNA)IBA
06/2021 - 12/2011
7Biological ProductsIBA
01/2017 - 11/2005
5p21-Activated KinasesIBA
12/2021 - 01/2017
5Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
08/2019 - 02/2013
5DNA (Deoxyribonucleic Acid)IBA
04/2012 - 11/2005
4GemcitabineFDA Link
03/2020 - 07/2009
4Exportin 1 ProteinIBA
05/2018 - 01/2014
4ResveratrolIBA
01/2016 - 08/2004
4Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2012 - 07/2009
4MI 319IBA
09/2012 - 12/2009
4Doxorubicin (Adriamycin)FDA LinkGeneric
06/2011 - 12/2003
4Vincristine (Oncovin)FDA LinkGeneric
09/2010 - 12/2003
4NF-kappa B (NF-kB)IBA
07/2009 - 11/2005
4GossypolIBA
09/2008 - 01/2005
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2007 - 08/2002
3NAD (NADH)IBA
12/2021 - 11/2019
3KPT-9274IBA
12/2021 - 11/2019
3EnzymesIBA
10/2021 - 12/2002
3Biomarkers (Surrogate Marker)IBA
06/2021 - 06/2013
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 08/2002
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 01/2008
3MI-219IBA
09/2012 - 12/2009
3Cisplatin (Platino)FDA LinkGeneric
05/2012 - 03/2006
3thymoquinoneIBA
06/2010 - 07/2009
3apogossypoloneIBA
04/2010 - 02/2008
3GenisteinIBA
03/2006 - 12/2003
3XK 469 (XK469)IBA
11/2003 - 12/2002
2Adenosine Triphosphate (ATP)IBA
12/2021 - 11/2019
2TransferasesIBA
12/2021 - 10/2021
2Niacinamide (Nicotinamide)FDA LinkGeneric
12/2021 - 10/2021
2EverolimusFDA Link
10/2021 - 11/2019
2rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
10/2021 - 01/2019
2Drug CombinationsIBA
12/2019 - 01/2011
2Peptides (Polypeptides)IBA
01/2019 - 06/2011
2AntioxidantsIBA
01/2017 - 02/2014
2Proteasome InhibitorsIBA
11/2016 - 03/2016
2F-Box ProteinsIBA
02/2016 - 02/2016
2KPT-185IBA
06/2014 - 02/2013
2Caspase 3 (Caspase-3)IBA
03/2014 - 09/2009
2SurvivinIBA
03/2014 - 07/2009
2PolyphenolsIBA
02/2014 - 08/2004
2CurcuminIBA
02/2014 - 08/2011
22-oxindole (oxindole)IBA
09/2012 - 05/2011
2nutlin 3IBA
09/2012 - 12/2009
2Protein Isoforms (Isoforms)IBA
01/2012 - 12/2002
2Apoptosis Regulatory ProteinsIBA
06/2011 - 09/2008
2PlatinumIBA
05/2011 - 01/2011
2ErbB Receptors (EGF Receptor)IBA
06/2010 - 05/2003
2Histones (Histone)IBA
04/2010 - 09/2009
2bryostatin 1IBA
03/2008 - 07/2004
2Prednisone (Sone)FDA LinkGeneric
04/2007 - 12/2003
2propionic acid (potassium propionate)IBA
11/2003 - 12/2002
2Etoposide (VP 16)FDA LinkGeneric
11/2003 - 12/2002
2trioctyl phosphine oxide (TOPO)IBA
12/2002 - 12/2002
1sotorasibIBA
05/2022
1Mechanistic Target of Rapamycin Complex 2IBA
10/2021
1CateninsIBA
10/2021
1Piwi-Interacting RNAIBA
08/2021
1Circular RNAIBA
08/2021
1Long Noncoding RNAIBA
08/2021
1130-nm albumin-bound paclitaxelIBA
03/2020
1Calcium Release Activated Calcium ChannelsIBA
03/2020
1RP4010IBA
03/2020
1CalciumIBA
03/2020
1lenvatinibIBA
12/2019
1Tyrosine Kinase InhibitorsIBA
12/2019
1Complement System Proteins (Complement)IBA
12/2019

Therapy/Procedure

34Therapeutics
05/2022 - 05/2003
7Drug Therapy (Chemotherapy)
10/2021 - 12/2002
4Oral Administration
05/2022 - 05/2010
2Chemoprevention
01/2011 - 09/2008
2Injections
09/2008 - 05/2003
2VAP-cyclo protocol
04/2007 - 01/2005